Cramer's TheStreet.com TV Recap: Fed Up With FedEx

"You won't see a turn in copper until maybe the third quarter of 2007, when [homebuilders] need to order more copper," he said.

For people looking to get into a copper play, Cramer suggested Lundin Mining (LMC Quote), a non-U.S. based copper stock.

Switching the topic to pharmaceuticals, Cramer told Task that a lot of market players have been long Boston Scientific (BSX Quote) because stents are popular.

However, in the end, the only way to play this business is through an impure stent play like Johnson & Johnson (JNJ Quote), which he owns for his charitable trust, Action Alerts PLUS, Cramer said.

People can't be reliant on stents because "it's not going to grow like it used to," he said. Cramer urged people to look at Johnson & Johnson as the "ultimate weak dollar play," not as a stents play.

Altria (MO Quote), which he also owns for his charitable trust, Action Alerts PLUS, is also a weak dollar play, he said.

Cramer recommended that people sell Boston Scientific as he believes "there's nothing to it," and hold Johnson & Johnson for the next six months as the "dollar weakness is going to keep bumping numbers."

Referring to The New York Times article on how Eli Lilly (LLY Quote) has been said to play down the risks of its Zyprexa drug, Cramer said, "nobody is unaware that you gain weight when you take it."